Form 4: Nuvation Bio Executive Sells Shares

Sentiment:

Insider Transaction (Form 4)


Gary Hattersley, CHIEF SCIENTIFIC OFFICER of Nuvation Bio Inc., sold 100,000 shares of common stock on August 19, 2026 for $7.09 per share.

Summary

  • Option exercise/conversion: acquired 100,000 Class A Common Stock at $1.87 ($187,000) on August 19, 2026; holds 100,000 after (Direct).
  • Open-market sale: disposed of 100,000 Class A Common Stock at $7.09 ($709,240) on August 19, 2026 (Direct).
  • Option exercise/conversion: disposed of 100,000 Stock Option (Right to Buy) on August 19, 2026; holds 400,000 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $709,240 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Gary Hattersley — Officer (CHIEF SCIENTIFIC OFFICER)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-19Option exercise/conversionClass A Common Stock100,000$2$187.0K100,000
2026-08-19Open-market saleClass A Common Stock100,000$7$709.2K0
2026-08-19Option exercise/conversionStock Option (Right to Buy)100,000——400,000

Key Dates

DateDescription
2026-08-19Option exercise/conversion (100,000 shares)
2026-08-19Open-market sale (100,000 shares)
2026-08-19Option exercise/conversion (100,000 shares)

Keywords

insider transaction, Form 4, NUVB, Nuvation Bio Inc., bearish, Gary Hattersley

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.